Clinical trials
Phase 1 Schizophrenia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 7 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Luye Pharma Group Ltd. | 3 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2 |
| Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2 |
| Otsuka Beijing Research Institute | 2 |
| Vigonvita Life Sciences | 2 |
| AstraZeneca | 1 |
| Chuanfu Song | 1 |
| Jiangsu Kanion Pharmaceutical Co., Ltd | 1 |
| Jiangsu Nhwa Pharmaceutical Co., Ltd. | 1 |
| Sichuan Kelun Pharmaceutical Co.,Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 20 |
| Anxiety Disorders | 1 |
| Disease | 1 |
| Major Depressive Disorder | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.